Why This Cannabis Stock Might Be the Best 1 to Invest in Today

Charlotte’s Web Holdings Inc (TSX:CWEB) has, time and again, proven to be one of the most consistent and stable cannabis stocks out there.

| More on:
Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis investors have no shortage of options when it comes to potential pot stocks to invest in. Unfortunately, there are many more bad ones out there than there are good ones.

From burning lots of cash to trading at very high multiples and not being anywhere near recording a profit, there are many reasons why value-oriented investors would want to steer clear of many marijuana companies.

However, there is one that has been separating itself from the pack lately, and that’s Charlotte’s Web Holdings (TSX:CWEB). The company has been able to do many of things other cannabis companies have struggled to do, and that’s grow while also posting a profit.

Charlotte’s Web recently released its second-quarter results, and the company made some strong strides in gaining even more of a presence throughout the U.S. market. With 7,871 retailers now carrying the company’s products, including multiple national retailers, the company has gained some significant first-mover advantages in the emerging industry.

While companies like Canopy Growth strategize about the best way to enter the CBD hemp market, Charlotte’s Web has already established a strong presence there and could become a market leader.

Although US$25 million during Q2 is not significant when compared to some of the numbers we’ve seen from companies selling THC products, what might matter more to investors is that the company has been able to consistently record a profit. It’s been a bit of a rarity in the industry, and with investors paying more attention to it as of late, Charlotte’s Web is a big step ahead of the competition.

In Q2, Charlotte’s Web recorded a profit of US$2.2 million. And while that’s down from the US$3.7 million that it recorded in the prior year, it’s still a very strong profit margin of 8.8%.

The company’s business model has proven to be sustainable, and especially with Charlotte’s Web planning more growth, that’s very important to investors, as it means the company may be able to avoid dipping into the equity markets to raise the additional funds needed to expand.

Lots of growth still on the way

Deanie Elsner, the company’s CEO, stated in the earnings release, “We believe we’ll continue to see additional large retailers coming onboard and expect an increase in the number of states and locations with our existing retail partners throughout the year. Kroger is the most recent example as they added four new states to their distribution in July, including Texas, which is the latest state to approve hemp CBD products.”

With a lot of hype growing around CBD, Charlotte’s Web is positioning itself for a lot of success in the industry. It’s recently launched a line of gummy products as well as a dozen products aimed at pets.

As the industry continues to make progress and break down barriers, we’ll likely see even more demand for CBD hemp products in the future. There’s a lot of growth coming down the pipe, and being able to generate positive cash flow is going to be more important than ever.

Bottom line

While marijuana companies selling non-hemp products might have more growth over the long term, it’s anyone’s guess as to how long it will take for pot to be legalized federally. With hemp, investors can see the market for where it is today, and there’s definitely a lot of excitement in the industry with many retailers jumping on board already.

Overall, Charlotte’s Web is in a good position to become a leader in CBD hemp products, and coupled with a profitable business, it could be a great long-term buy today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »